Background Sarcopenia, a progressive reduction of muscle mass and function, is associated
with adverse outcomes in the elderly. Sarcopenia and muscle atrophy are not equal …

To date, sarcopenia is considered a patient-specific imaging biomarker able to predict
clinical outcomes. Several imaging modalities, including dual-energy X-ray absorptiometry …

Sarcopenia is a clinical condition mainly affecting the elderly that can be associated in a
long run with severe consequences like malnutrition and frailty. Considering the progressive …

Sarcopenia is a disease characterized by decreased skeletal muscle mass, strength, and
loss of function that can impair quality of life and increase physical disability, adverse …

Sarcopenia is currently considered a geriatric syndrome increasing in older people. The
consequences of sarcopenia–in terms of impaired mobility, limited self-sufficiency and …

Sarcopenia indicates a loss of skeletal muscle mass, a condition that leads to a decline in
physical performance. In 2018, the European Working Group on Sarcopenia in Older People …

Background The measurement or estimation of muscle mass plays an important role in the
diagnosis of sarcopenia. Beside dual-energy X-ray absorptiometry (DXA), several …

05 EDITORIAL MARZETTI_04 LORD_c 07/09/12 11: 27 Page97 biological determinations)
might be required to obtain a comprehensive characterization of muscle health in older …

Sarcopenia is the advanced and generalized loss of muscle mass and strength among the
elderly population and is a cause of adverse outcomes. Methods used for the diagnosis of …

Sarcopenia encompasses the loss of muscle mass and strength/function during aging.
Several methods are available for the estimation of muscle or lean body mass. Popular …